Eagle Pharmaceuticals | 8-K: Current report
Eagle Pharmaceuticals | 8-K: Current report
Eagle Pharmaceuticals | 8-K: Current report
Eagle Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Eagle Pharmaceuticals | 8-K: Current report
Eagle Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Scott Tarriff(17.6%),Tarriff 2016 Generation Skipping Exempt Family Trust DTD 12/28/2016(7.6%), etc.
Eagle Pharmaceuticals | NT 10-K: Others
Eagle Pharmaceuticals | 8-K: Current report
Eagle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Tarriff Scott
Eagle Pharmaceuticals | 8-K: Current report
Eagle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cahill Brian Joseph
Eagle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Tarriff Scott
Eagle Pharmaceuticals | 8-K: Current report
Eagle Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Michael Graves(1.8%)
Eagle Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.91%)
Eagle Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(6.0%),Janus Henderson Triton Fund(3.9%)
Eagle Pharmaceuticals | 8-K: Current report
Eagle Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals
Eagle Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(8.2%),Orin H(8.2%)
Eagle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cahill Brian Joseph
No Data